文献检索文档翻译深度研究

邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

不再提醒

插件&应用

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

高级版

套餐订阅购买积分包

AI 工具

文献检索文档翻译深度研究

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2025

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

作者信息

Sheikh Aziz, McMenamin Jim, Taylor Bob, Robertson Chris

机构信息

Usher Institute, University of Edinburgh, Edinburgh EH8 9AG, UK.

Public Health Scotland, Glasgow, UK.

出版信息

Lancet. 2021 Jun 26;397(10293):2461-2462. doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.

DOI:10.1016/S0140-6736(21)01358-1

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8201647/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f108/8201647/d2d1da51051a/fx1_lrg.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f108/8201647/d2d1da51051a/fx1_lrg.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f108/8201647/d2d1da51051a/fx1_lrg.jpg

相似文献

[1]

SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.

Lancet. 2021-6-26

[2]

COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.

J Glob Health. 2022-7-9

[3]

Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity.

J Infect Public Health. 2024-6

[4]

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.

MMWR Morb Mortal Wkly Rep. 2021-8-27

[5]

Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study.

Microbiol Spectr. 2021-12-22

[6]

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.

PLoS One. 2021

[7]

Severity of omicron variant of concern and effectiveness of vaccine boosters against symptomatic disease in Scotland (EAVE II): a national cohort study with nested test-negative design.

Lancet Infect Dis. 2022-7

[8]

Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.

PLoS One. 2021

[9]

Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.

Lancet. 2021-11-13

[10]

Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.

Lancet. 2022-1-1

引用本文的文献

[1]

BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5-11 years in Scotland.

J Glob Health. 2025-8-29

[2]

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.

BMC Infect Dis. 2025-8-17

[3]

Comparative Analysis of Severe Clinical Outcomes in Hospitalized Patients with RSV, Influenza, and COVID-19 Across Early and Late COVID-19 Pandemic Phases (2021-2024).

J Clin Med. 2025-7-10

[4]

Different SARS-CoV-2 variants inhibited by RRM designed peptide.

PLoS One. 2025-7-22

[5]

Use of cell phone data to correct Île-de-France population estimates and SARS-CoV-2 incidence, July to September, 2021: a proof-of-concept exercise.

Euro Surveill. 2025-6

[6]

Maternal and Perinatal Outcomes of SARS-CoV-2 and Variants in Pregnancy.

Matern Fetal Med. 2023-3-27

[7]

Knowledge Mapping of COVID-19 and Asthma/Allergic Rhinitis: A Visual and Bibliometric Analysis.

J Asthma Allergy. 2025-5-6

[8]

COVID-19 hospitalization in vaccinated and non-vaccinated patients: Clinical profile and outcomes.

Braz J Infect Dis. 2025

[9]

Nutritional Risk Score (NRS-2002) as a Predictor of In-Hospital Mortality in COVID-19 Patients: A Retrospective Single-Center Cohort Study.

Nutrients. 2025-4-6

[10]

Factors Associated With the Transmission of the Delta Severe Acute Respiratory Syndrome Coronavirus 2 Variant in Households: The Israeli COVID-19 Family Study (ICoFS).

J Infect Dis. 2025-4-15

本文引用的文献

[1]

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply.

N Engl J Med. 2021-12-16

[2]

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

Nat Med. 2021-7

[3]

Cohort Profile: Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II) Database.

Int J Epidemiol. 2021-8-30

[4]

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.

BMJ. 2021-5-13

[5]

Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.

Lancet. 2021-5-1

[6]

Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): protocol for an observational study using linked Scottish national data.

BMJ Open. 2020-6-21

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

推荐工具

医学文档翻译智能文献检索